Sorting out the new HSV type specific antibody tests

This review will delineate performance characteristics and limitations, as far as they are known, of die new glycoprotein G based, type specific HSV s erologies. Several of these tests have been FDA approved in the United Stat es for use in adults. With the departure of Gull/Meridian from the HSV sero logy market, it is important for clinicians to understand the sources and c laims of the remaining type specific tests. Moreover, inaccurate tests usin g crude antigen preparations remain on the market. These tests are identifi ed based on product insert information provided by company representatives.